We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App

New Scientific Method Halves Polio Detection Time

By LabMedica International staff writers
Posted on 23 Aug 2023
Print article
Image: The time to detect polio can be halved using the DDNS technique (Photo courtesy of Freepik)
Image: The time to detect polio can be halved using the DDNS technique (Photo courtesy of Freepik)

Polio, an infectious disease caused by the poliovirus, spreads mainly through contact with contaminated food and water due to infected feces. While some individuals remain asymptomatic, polio can be particularly severe for infants and children under five, resulting in permanent paralysis or even death. The World Health Organization (WHO) recognizes delayed detection as a significant hurdle in their 2022-2026 plan to eradicate polio. Presently, nations with active polio outbreaks ship stool samples worldwide for lengthy, complex lab tests, leading to time-consuming confirmation of results. Detecting polio more swiftly in outbreak regions can allow authorities to respond promptly with focused vaccination efforts, curbing the spread of the virus. Now, a novel technique that has been shown to halve the time to detect polio could support global efforts to eradicate the infectious disease and help save lives.

Collaborative research supported by the Medicines and Healthcare Products Regulatory Agency (MHRA) demonstrated the efficacy of the Direct Molecular Detection and Nanopore Sequencing (DDNS) technique in detecting polio outbreaks. DDNS not only preserves valuable time but also reduces costs for public health bodies. This marks the first application of such a scientific technique for polio detection, building on its use in identifying COVID-19, Ebola, measles, and monkeypox. By enabling in-country testing instead of shipping samples abroad for specialized lab assessments, transport and testing delays shrink from an average of 42 days to 19 days. The research, conducted in the Democratic Republic of Congo (DRC) over six months, exhibited DDNS tests to be approximately 23 days quicker than the standard method, boasting over 99% accuracy.

“We are standing at a delicate and pivotal moment for the eradication of polio. While vaccination programs have seen polio disappear in many countries, the delayed detection of outbreaks poses a major threat to those efforts,” said Javier Martin, Principal Scientist in Virology at the MHRA. “By implementing detection methods such as DDNS, we can identify where outbreaks are and which polio strain is present much more quickly, allowing us to act at the earliest opportunity.”

“This method allows the rapid confirmation of polio strains, facilitating swifter vaccine responses that can reduce the number of polio cases stemming from an outbreak,” said Dr. Alex Shaw, Research Fellow in the School of Public Health at Imperial College London. “The sequencing technology used in this method is easily adapted for the detection and typing of other organisms. This rollout will therefore provide a foundation of skills and experience that can be redirected to the genomic surveillance of other pathogens as needed.”

Related Links:

Platinum Supplier
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Gold Supplier
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
cTnI Test
OnSite Troponin I Combo Rapid Test
One Step Card Test
CerTest Transferrin

Print article


Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more


view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more


view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more


view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more


view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more


view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more


view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.